Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Nov 30, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 118.46B | -6.38%112.46B | 6.94%498.49B | 6.65%123.31B | 13.80%120.12B | 5.12%466.13B | 4.97%131.94B | 3.93%113.02B | 7.35%115.62B | 4.19%105.56B |
| Cost of revenue | 43.97B | -9.53%41.71B | 6.14%199.1B | 7.91%50.41B | 12.90%46.1B | 2.92%187.58B | 5.51%56.37B | 1.88%43.66B | 5.14%46.71B | -1.73%40.84B |
| Gross profit | 74.49B | -4.42%70.75B | 7.48%299.39B | 5.79%72.9B | 14.37%74.02B | 6.65%278.56B | 4.57%75.57B | 5.27%69.36B | 8.91%68.91B | 8.30%64.72B |
| Operating expense | 60.87B | 2.44%58.11B | 3.99%241.88B | 3.89%61.43B | 5.67%56.73B | 1.73%232.61B | 0.38%62.84B | 2.00%56.96B | 3.58%59.13B | 1.04%53.68B |
| Staff costs | --17.13B | 2.31%16.14B | 5.03%79.27B | 4.15%15.99B | 5.40%15.78B | 2.17%75.48B | 2.13%29.17B | 2.74%15.99B | 3.10%15.35B | 0.70%14.97B |
| Selling and administrative expenses | --3.18B | 0.97%2.91B | 6.67%71.93B | 14.97%2.4B | 11.56%2.89B | 2.14%67.44B | 0.45%59.49B | 28.50%3.28B | 48.86%2.08B | -9.29%2.59B |
| -Selling and marketing expense | --3.18B | 0.97%2.91B | 2.49%44.13B | 14.97%2.4B | 11.56%2.89B | 1.65%43.06B | -1.26%35.1B | 28.50%3.28B | 48.86%2.08B | -9.29%2.59B |
| -General and administrative expense | ---- | ---- | 14.04%27.81B | ---- | ---- | 3.03%24.38B | ---- | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | -3.79%33.21B | ---- | ---- | 2.84%34.52B | ---- | ---- | ---- | ---- |
| -Depreciation | ---- | ---- | -3.89%32.88B | ---- | ---- | 2.76%34.21B | ---- | ---- | ---- | ---- |
| -Amortization | ---- | ---- | 6.75%332M | ---- | ---- | 11.47%311M | ---- | ---- | ---- | ---- |
| Rent and land expenses | --5.97B | 4.37%6.04B | 0.11%23.78B | 1.91%5.77B | 2.32%5.78B | -0.12%23.75B | 0.94%6.74B | -0.28%5.7B | -0.46%5.66B | -0.88%5.65B |
| Other operating expenses | --34.59B | 2.29%33.02B | 7.20%33.69B | 3.45%37.28B | 5.93%32.28B | 0.05%31.42B | -2.53%-67.08B | -0.07%31.99B | 2.64%36.04B | 2.58%30.47B |
| Operating profit | 13.61B | -26.93%12.64B | 25.17%57.51B | 17.32%11.47B | 56.66%17.3B | 41.26%45.95B | 31.72%12.74B | 23.46%12.4B | 58.09%9.77B | 66.41%11.04B |
| Net non-operating interest income (expenses) | -1.77B | 1.43%-1.45B | -63.87%-5.82B | -107.54%-1.57B | -98.51%-1.47B | 18.69%-3.55B | -41.13%-1.32B | 34.96%-735M | 34.60%-756M | 35.46%-739M |
| Non-operating interest income | --199M | -4.46%471M | -3.93%2.06B | -16.57%448M | -9.21%493M | 164.20%2.14B | 22.08%470M | 173.15%590M | 300.75%537M | 624.00%543M |
| Non-operating interest expense | --1.96B | -2.19%1.92B | 38.38%7.88B | 55.99%2.02B | 52.89%1.96B | 9.93%5.69B | 35.58%1.79B | -1.56%1.33B | 0.23%1.29B | 5.08%1.28B |
| Net investment income | -20M | -166.77%-434M | 81.94%2.77B | 3.72%670M | 209.52%650M | -13.22%1.52B | 65.17%-155M | 547.24%822M | -55.54%646M | -66.13%210M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 178M | 3.65B | 0 | 0 | 0 | |||||
| Income from associates and other participating interests | 1.21B | -51.46%498M | 14.37%3.69B | 191.07%1.3B | 49.78%1.03B | 19.86%3.22B | 17.82%1.38B | 27.34%708M | 41.77%448M | 6.37%685M |
| Special income (charges) | -1.7B | -767.50%-1.04B | 26.83%-5.23B | 20.91%-1.12B | -424.32%-120M | -579.28%-7.15B | -2,378.20%-5.23B | -762.20%-543M | -595.07%-1.41B | 105.14%37M |
| Less:Other special charges | --1.6B | 767.50%1.04B | 50.29%2.34B | -59.89%223M | 424.32%120M | 139.21%1.56B | 112.53%544M | 700.00%492M | 173.89%556M | -114.62%-37M |
| Less:Write off | --103M | ---- | -48.27%2.89B | ---- | ---- | 11.42%5.59B | 2.94%4.69B | --51M | ---- | ---- |
| Other non-operating income (expenses) | 1.15B | 3,075.00%254M | 22.83%694M | -16.00%42M | -89.33%8M | 12.77%565M | 90.12%308M | 369.39%132M | -70.76%50M | -65.44%75M |
| Income before tax | 12.68B | -39.84%10.46B | 41.18%57.25B | 27.19%11.13B | 53.81%17.39B | 16.17%40.55B | -18.00%7.72B | 4.43%12.78B | 29.39%8.75B | 74.01%11.31B |
| Income tax | 3.73B | -24.05%3.15B | 119.96%16.58B | 158.58%5.09B | 72.13%4.15B | 25.32%7.54B | -99.42%25M | 22.07%3.14B | 215.07%1.97B | 177.74%2.41B |
| Net income | 8.95B | -44.78%7.32B | 23.19%40.67B | -10.98%6.03B | 48.85%13.25B | 14.27%33.01B | 50.31%7.69B | -0.26%9.65B | -20.00%6.78B | 58.03%8.9B |
| Net income continuous operations | --8.94B | -44.78%7.32B | 23.19%40.67B | -10.99%6.03B | 48.85%13.25B | 14.27%33.01B | 50.31%7.69B | -0.26%9.65B | -20.00%6.78B | 58.04%8.9B |
| Noncontrolling interests | 441M | -25.06%320M | -17.74%1.15B | -162.92%-224M | 18.61%427M | 32.32%1.39B | 70.21%320M | 26.69%356M | 20.27%356M | 25.44%360M |
| Net income attributable to the company | 8.5B | -45.43%7B | 25.00%39.53B | -2.57%6.26B | 50.13%12.82B | 13.59%31.62B | 49.53%7.37B | -1.05%9.29B | -21.46%6.42B | 59.78%8.54B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 8.5B | -45.43%7B | 25.00%39.53B | -2.57%6.26B | 50.13%12.82B | 13.59%31.62B | 49.53%7.37B | -1.05%9.29B | -21.46%6.42B | 59.78%8.54B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 28.86 | -43.26%23.06 | 26.03%126.33 | -2.59%19.83 | 50.13%40.64 | 18.08%100.24 | 47.74%23.365 | 3.23%29.4455 | -16.99%20.3573 | 68.92%27.07 |
| Diluted earnings per share | 24.22 | -43.70%19.45 | 25.78%107.25 | -2.66%16.85 | 50.02%34.55 | 17.40%85.27 | 47.90%19.87 | 2.60%25.06 | -17.71%17.31 | 67.61%23.03 |
| Dividend per share | 0 | 0 | 32.43%24.5 | 35.29%11.5 | 0 | 42.31%18.5 | 42.86%10 | 0 | 41.67%8.5 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |